A bill to require the Administrator of the Centers for Medicare & Medicaid Services to submit a report regarding the use of coverage and reimbursement authorities to protect the markets for active pharmaceutical ingredients and key staring materials.
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
Based on the bill's title, this bill would require the Centers for Medicare & Medicaid Services (CMS) Administrator to submit a report to Congress examining how CMS's coverage and reimbursement authorities could be used to protect domestic markets for active pharmaceutical ingredients and key starting materials. The bill appears focused on understanding potential policy tools rather than implementing new requirements directly.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.